Proven. Safe. Effective.

ActivePure® Is Backed By Comprehensive
Laboratory & Real World Testing

At Sanalife, we believe it's imperative to offer our customers solutions that improve indoor environments that promote health and wellness. ActivePure® is the leading purification technology to reduce harmful contaminants in the air and on surfaces. The technology has a proven track record and is supported by exhaustive testing in FDA-Compliant and third-party laboratories. The FDA reviewed the testing results listed below as part of the Class II Medical Device Clearance process, unless otherwise noted.*

*The application of ActivePure® should complement existing regulatory guidelines for sanitization and disinfection and not replace them.

ActivePure SARS-CoV-2 Testing

(the virus that causes COVID-19)

Testing of the SARS-CoV-2 virus was completed in August 2020 (surface) and in December 2020 (airborne). The results of the laboratory testing revealed extraordinary reduction levels of the virus that causes COVID-19.

Airborne Reduction SARS-CoV-2

The Aerus Pure & Clean is scientifically proven to reduce over 99.96% of airborne SARS-CoV-2 viral particles (the virus that causes COVID-19).* Laboratory testing showed a dramatic airborne reduction of the virus within 3 minutes. The testing of the SARS-CoV-2 viral reduction was conducted in FDA-Compliant laboratories against the live SARS-CoV-2 virus (not proxy or surrogate strains).

*Results are based on testing conducted at UTMB BSL Level 3 Lab with assistance from BSL Level 4 Lab, complying with FDA protocols in a FDA Certified Compliant Laboratory (Aerus Pure & Clean).

Surface Reduction SARS-CoV-2

The Aerus Hydroxyl Blaster is scientifically proven to reduce over 99.98% of SARS-CoV-2 viral particles (the virus that causes COVID-19) on surfaces.* Laboratory testing showed a dramatic surface reduction of the virus within 7 hours. The testing of the SARS-CoV-2 viral reduction was conducted in FDA-Compliant laboratories against the live SARS-CoV-2 virus (not proxy or surrogate strains).

*Results are based on testing conducted at MRIGlobal, an independent, FDA-Compliant laboratory. The reduction percentages were measured incrementally over natural degradation of SARS-CoV-2. Outside of control group - over 99.9% reduction of the SARS-CoV-2 virus (Aerus Hydroxyl Blaster).

ActivePure® Pathogen & Contaminants Testing

Laboratory testing results of the pathogens and contaminants listed below
revealed extraordinary levels of reduction using ActivePure Technology.

Airborne Reduction of Influenza
(H5N8 / Avian-Bird Flu)

Results are based on laboratory testing conducted to demonstrate the use of ActivePure® Technology in substantially reducing airborne contaminants. Field results may vary based on environmental conditions. These results have not been evaluated by the FDA.

Airborne Reduction of RNA Virus
(MS2 Bacteriophage)

Results are based on testing conducted at Aerosol Research and Engineering Laboratories, complying with FDA Protocols in a FDA Certified Compliant Laboratory Net Log Reduction of MS2 Bacteriophage Virus Bioaerosol (Aerus Medical Guardian).

Airborne Reduction of DNA Virus
(Phi-X174 Bacteriophage)

Results are based on testing conducted at Aerosol Research and Engineering Laboratories, complying with FDA Protocols in a FDA Certified Compliant Laboratory Net Log Reduction Phi-X174 of Bacteriophage Virus Bioaerosol (Aerus Medical Guardian).

Airborne Reduction of H1N1 Virus
(Swine Flu Microbes)

Results are based on laboratory testing conducted to demonstrate the use of ActivePure® Technology in substantially reducing airborne contaminants. Field results may vary based on environmental conditions. These results have not been evaluated by the FDA.

Volatile Organic Compounds
(TVOC Reduction)

Results are based on testing conducted at Danish Technological Institute. Testing was completed with the air purifier installed within a seal 20 cubic meter room. Experiment was designed to measure the reduction rate during the use of the Beyond Guardian.

Cigarette Smoke Reduction
(Particulate Matter <0.8 Microns)

Results are based on testing conducted at Danish Technological Institute. Testing was completed with the air purifier installed within a seal 20 cubic meter room. Experiment was designed to measure the reduction rate during the use of the Beyond Guardian.

Cigarette Smoke Reduction
(Particulate Matter 2.5 Microns)

Results are based on testing conducted at Danish Technological Institute. Testing was completed with the air purifier installed within a seal 20 cubic meter room. Experiment was designed to measure the reduction rate during the use of the Beyond Guardian.

Surface Reduction of Bacteria
(Within Hotel Facilities)

Results are based on testing conducted using ActivePure® Technology within a Hotel Facility. The results are combined from testing conducted within 3 rooms.

Surface Reduction of fungi
(Within Hotel Facilities)

Results are based on testing conducted using ActivePure® Technology within a Hotel Facility. The results are combined from testing conducted within 3 rooms.

Reduction of Airborne Fungal Mold (Aspergillus Niger & Bacillus Globigi)

Results are based on testing conducted in Eastern Health Canada Medical Surgical & Cardio ICU settings to demonstrate the use of ActivePure® Technology in substantially reducing airborne contaminants. These results have not been evaluated by the FDA.

Reduction of Airborne
Gram-Positive Bacteria Bioareosol
(Staphylococcus Epidermidis)

Results are based on testing conducted in Eastern Health Canada Medical Surgical & Cardio ICU settings to demonstrate the use of ActivePure® Technology in substantially reducing airborne contaminants. These results have not been evaluated by the FDA.

Reduction of Airborne Gram-Negative Bacteria Bioareosol (Erwina Herbicola)

Results are based on testing conducted in Eastern Health Canada Medical Surgical & Cardio ICU settings to demonstrate the use of ActivePure® Technology in substantially reducing airborne contaminants. These results have not been evaluated by the FDA.

The Pathogens ActivePure® Can Combat Against

  • SARS-CoV-2
  • Staphylococcus Aureus
  • Aspergillus niger endospores (toxic black mold surrogate)
  • H1N1 Influenza (Swine Flu)
  • H5N8 Influenza (Bird Flu)
  • MRSA
  • Bacillus globigii (C. difficile & anthrax surrogate)
  • MS2 Bacteriophage - RNA Virus
  • Staphylococcus epidermidis (Gram +)
  • PhiX-174 - DNA Virus
  • Erwinia Herbicola (Gram -)
  • Listeria monocytogenes
  • Murine Norovirus
  • E. Coli
  • Candida auris (fungus)
  • Botrytis cinerea (fungus)
  • Sclerotinia sclerotiorum (fungus)
  • Legionella pneumophila (bacteria)
  • Aspergillus versicolor (fungus)
  • Clostridium difficile (endospore)
  • Salmonella enterica (bacteria)

Making Every
Indoor Space Safer.

ActivePure® Technology is an active purification technology that puts back into the air the same therapeutic molecules that make our outdoor air safe – molecules that actively neutralize pathogens and volatile organic compounds (VOCs) as they enter the space. ActivePure® provides a layer of protection that reduces airborne and surface pathogens quickly and effectively.

Learn About ActivePure®
Dark Blue Arrow Pointing Right.

The Only Blueprint For IAQ

Improving your indoor air quality has never been easier. Fully customizable and scalable in design, our air purification systems can cover any space. Explore our high-quality and advanced HVAC Induct and portable air purification solutions.